Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/10/2017 01/11/2017 01/12/2017 01/13/2017 01/17/2017 Date
23.68(c) 23.7(c) 23.71(c) 23.69(c) 23.64(c) Last
62 154 877 35 797 254 14 662 229 14 657 842 13 180 932 Volume
-0.29% +0.08% +0.04% -0.08% -0.21% Change
More quotes
Financials ($)
Sales 2016 196 M
EBIT 2016 -111 M
Net income 2016 -7,07 M
Debt 2016 157 M
Yield 2016 -
Sales 2017 245 M
EBIT 2017 -54,0 M
Net income 2017 -69,0 M
Debt 2017 148 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 24,2x
EV / Sales2017 19,3x
Capitalization 4 591 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
01/13 ARIAD SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of A..
01/13 Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharm..
01/12 ARIAD PHARMACEUTICALS : to Present at the 35th Annual J.P. Morgan Healthcare Con..
01/12 ARIAD PHARMACEUTICALS : Takeda to acquire ARIAD Pharmaceuticals
01/11 TAKEDA PHARMACEUTICAL : to buy Ariad in $4.7 billion cash deal
01/10 ARIAD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Terminat..
01/10 ARIAD PHARMACEUTICALS, INC. : Ariad Pharmaceuticals Cash Acquisition by Takeda P..
01/10 ARIAD PHARMACEUTICALS : arises
01/10 Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
01/10 ARIAD PHARMACEUTICALS : Japan's Takeda group buys US cancer drug maker Ariad
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/17Google Is Watching You  
01/14Top Performing Breakout Stocks of the Week
2
01/13Takeda, Japan’s largest #pharma group, will purchase Ariad Pharmaceuticals fo..
3
01/13$ARIA Feb24 16 Put Buyers +10k for $0.065
1
01/12ARIAD Pharmaceuticals upgraded by Zacks Investment Research to strong-buy. $2..
12
More tweets
Qtime:74
News from SeekingAlpha
01/11 VALEANT : Forget About Acquisition. Takeda Has Bought ARIAD
01/11 BIOTECH FORUM DAILY DIGEST : Keytruda Continues To Power Merck; Revisiting Invit..
01/10 Google Is Watching You
01/10 Takeda to acquire ARIAD Pharmaceuticals (ARIA) - M&A Call Slides
01/10 BIOTECH FORUM DAILY DIGEST : Biotech Continues To Rally. Revisiting Merrimack Ph..
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 20,6 $
Spread / Average Target -13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paris Panayiotopoulos President, Chief Executive Officer & Director
Alexander John Denner Chairman
Manmeet Singh Soni Chief Financial Officer, Treasurer & Executive VP
Timothy P. Clackson Chief Scientific Officer
Nicholas Ventresca Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS,..90.03%4 591
AMGEN, INC.5.88%115 159
GILEAD SCIENCES, INC.0.42%94 738
CELGENE CORPORATION-0.69%89 110
REGENERON PHARMACEUTIC..-1.05%38 311
ACTELION LTD4.58%24 564
More Results